Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: Its relationship to lymph node metastasis

被引:93
作者
Kurahara, H
Takao, S
Maemura, K
Shinchi, H
Natsugoe, S
Aikou, T
机构
[1] Kagoshima Univ, Res Ctr Life Sci Resources, Fac Med, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Fac Med, Div Surg Oncol, Dept Oncol, Kagoshima 8908520, Japan
关键词
D O I
10.1158/1078-0432.CCR-04-0379
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to evaluate the expression of vascular endothelial growth factor (VEGF)-C and -D in pancreatic cancer and to reveal its relation to lymph node metastasis. Experimental Design: Formalin-fixed, paraffin-embedded blocks were obtained from 58 patients with pancreatic head cancer. All of the patients underwent a curative resection. The total number of resected lymph nodes was 1,058. The expressions of VEGF-C and -D were evaluated by immunohistochemical staining. To evaluate the relation to lymph node metastasis, the expressions of VEGF-C and -D between the marginal and central portions in the tumor were compared. When >25% of the tumor cells showed distinct staining, the portion was judged as high expression. Results: The two groups with high expression of VEGF-C (P = 0.015) and VEGF-D (P = 0.020) in the marginal portion had a significantly higher incidence of lymph node metastasis compared with the groups with low expression, respectively. Furthermore, the group with high expression of both VEGF-C and -D in the marginal portion had a higher incidence of lymph node metastasis compared with the group with low expression (P = 0.007). The 5-year survival rate of patients with high expression of both VEGF-C and -D in the marginal portion was significantly lower than that of patients with low expression of both VEGF-C and -D (P = 0.017). Conclusions: VEGF-C and -D expression in tumor cells in the marginal portion of the tumor significantly associated with lymphatic metastasis and prognosis in patients with pancreatic head cancer.
引用
收藏
页码:8413 / 8420
页数:8
相关论文
共 35 条
  • [1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [2] Clinical significance of vascular, endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
    Arinaga, M
    Noguchi, T
    Takeno, S
    Chujo, M
    Miura, T
    Uchida, Y
    [J]. CANCER, 2003, 97 (02) : 457 - 464
  • [3] LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
    Banerji, S
    Ni, J
    Wang, SX
    Clasper, S
    Su, J
    Tammi, R
    Jones, M
    Jackson, DG
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (04) : 789 - 801
  • [4] Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium
    Breiteneder-Geleff, S
    Soleiman, A
    Kowalski, H
    Horvat, R
    Amann, G
    Kriehuber, E
    Diem, K
    Weninger, W
    Tschachler, E
    Alitalo, K
    Kerjaschki, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) : 385 - 394
  • [5] Vascular endothelial growth factor C induces angiogenesis in vivo
    Cao, YH
    Linden, P
    Farnebo, J
    Cao, RH
    Eriksson, A
    Kumar, V
    Qi, JH
    Claesson-Welsh, L
    Alitalo, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) : 14389 - 14394
  • [6] FIDLER IJ, 1995, CANC METASTASIS REV, V14, P323
  • [7] USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES
    HSU, SM
    RAINE, L
    FANGER, H
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) : 577 - 580
  • [8] JAYA K, 2003, CANCER RES, V63, P713
  • [9] Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
    Jeltsch, M
    Kaipainen, A
    Joukov, V
    Meng, XJ
    Lakso, M
    Rauvala, H
    Swartz, M
    Fukumura, D
    Jain, RK
    Alitalo, K
    [J]. SCIENCE, 1997, 276 (5317) : 1423 - 1425
  • [10] Proteolytic processing regulates receptor specificity and activity of VEGF-C
    Joukov, V
    Sorsa, T
    Kumar, V
    Jeltsch, M
    ClaessonWelsh, L
    Cao, YH
    Saksela, O
    Kalkkinen, N
    Alitalo, K
    [J]. EMBO JOURNAL, 1997, 16 (13) : 3898 - 3911